The first half of the meeting focused on new and existing vaccine clinical trials in Uganda, The Gambia, and the UK. Our members discussed implementation aspects and shared results, insights and valuable lessons from studies on the pertussis vaccine, the respiratory syncytial virus (RSV) vaccine and their research on maternal measles.

The latter half of the meeting focused on the challenges and implementation of pregnancy registries. Members discussed observations from pilot testing a WHO protocol for antenatal care attendance for maternal immunisation and specific examples of pregnancy registries in Uganda and The Gambia. The day was concluded by a presentation of the Safety Platform for Emergency vACcines (SPEAC) and the vaccine safety tools, resources, and expertise that it provides throughout the vaccine development process to enhance safety and build confidence in vaccines.

The meeting was open to IMPRINT members as well as interested parties and the more than 60 attendees sparked lively discussions during the Q&A rounds. The session concluded the 3-day INMIS symposium and was a great end to a successful and inspiring conference.

We would like to thank all attendees for making the IMPRINT meeting a great success!

IMPRINT is now in its second funding period and will officially run for an additional 24 months, until the end of November 2025. We recently closed our first open call during this second funding period for Progression Grants and are currently evaluating grant applications. The results will be announced shortly, and new projects will begin within the next few months. A next IMPRINT call on public engagement activities will be announced shortly. We are always looking for new members to support our work and to champion maternal and neonatal immunisation efforts within the network and beyond.

‍